Abstract
Wegener's granulomatosis (WG) is a multiorgan system disease of unknown etiology characterized by granulomatous inflammation, tissue necrosis, and variable degrees of vasculitis in small- and medium-sized blood vessels. In patients with WG, the musculoskeletal system can be involved before other typical symptoms of the disease. Also in WG, pneumothorax can develop as a rare complication. In this paper, we report a case with WG who had early articular involvement in the absence of classic features of illness and had pneumothorax which resulted from the rupture of the sub-pleural nodule. The aim of this work is to increase the awareness of early articular involvement in WG and the pneumothorax possibility especially in cases with cavitated nodules closure to pleura. This case emphasizes that early diagnosis and treatment is very important in avoiding further complications.
Similar content being viewed by others
References
Leavitt RY, Fauci AS, Bloch D, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33:1101–7.
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.
Stone JH, Hofman GS. Wegener’s granulomatosis and lymphomatoid granulomatosis. In: Hoschberg MC, Silman AJ, Smolen JS, et al. (eds) Rheumatology, 3rd ed. St. Louis: Mosby; 2003. pp. 1635–48.
Abdou N, Kullman G, Hoffman GS, Sharp GC, Specks U, McDonald T, et al. Wegener’s granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J Rheumatol. 2002;29:309–16.
Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488–98.
Fauci AS, Haynes BF, Katz P, Wolff SM, et al. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85.
Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener’s granulomatosis. Rheumatology. 2002;41:572–81.
Delevaux I, Khellaf M, Andre M, Michel JL, Piette JC, Aumaitre O. Spontaneous pneumothorax in Wegener's granulomatosis. Chest. 2005;128:3074–5.
Epstein DM, Gefter WB, Miller WT Gohel V, Bonavita JA. Spontaneous pneumothorax: an uncommon manifestation of Wegener's granulomatosis. Radiology. 1980;135:327–8.
Jaspan T, Davison AM, Walker WC. Spontaneous pneumothorax in Wegener’s granulomatosis. Thorax. 1982;37:774–5.
Wolffenbuttel BH, Weber RF, Kho GS. Pyopneumothorax: a rare complication of Wegener’s granulomatosis. Eur J Respir Dis. 1985;67:223–7.
Ogawa M, Azemoto R, Makino Y, Mori Y, Ueda S, Wakashin M, et al. Pneumothorax in a patient with Wegener’s granulomatosis during treatment with immunosuppressive agents. J Intern Med. 1991;229:189–92.
Bulbul Y, Ozlu T, Oztuna F. Wegener’s granulomatosis with parotid gland involvement, pneumothorax. Med Princ Pract. 2003;12:133–7.
Ates A, Karaaslan Y, Yıldız G, Gunesen O, Han S. A case of Wegener’s granulomatosis complicated with hydropneumothorax. J Clin Rheumatol. 2006;12:264–5.
Mies Richie A, Francis ML. Diagnostic approach to polyarticular joint pain. Am Fam Physician. 2003;68:1151–60.
Pavelka K Jr, Dostal C, Rossmann P, Kraus H, Matousovic K, Vrabec J. Wegener’s granulomatosis with bilateral necrotizing scleritis, polyarthritis and renal failure efficiently treated with immunosuppressive therapy. Clin Rheumatol. 1986;5:112–7.
El-Gabalawy HS, Duray P, Goldbach-Mansky R. Evaluating patients with arthritis of recent onset: studies in pathogenesis and prognosis. JAMA. 2000;284:2368–73.
Brazzelli V, Vassallo C, Baldini F, Ravelli A, Martini A, Borroni G. Wegener's granulomatosis in a child: cutaneous findings as the presenting signs. Pediatr Dermatol. 1999;16:277–80.
Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, Stern JB, et al. Cutaneous pathology in Wegener’s granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol. 1995;19:161–72.
Stein CM. Immunoregulatory drugs. In: Ruddy S, Harris ED (eds) Kelley’s textbook of rheumatology. 6th edn., Philadelphia: WB Saunders Company, 2001. pp. 879–98.
Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener’s granulomatosis. Arthritis Rheum. 1997;40:2187–98.
Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener’s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med. 1990;89:403–10.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sezer, I., Kocabas, H., Melikoglu, M.A. et al. Spontaneous pneumothorax in Wegener's granulomatosis: a case report. Mod Rheumatol 18, 76–80 (2008). https://doi.org/10.1007/s10165-007-0007-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-007-0007-y